Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
J Alzheimers Dis. 2011;26(4):735-44. doi: 10.3233/JAD-2011-110065.
Risk scores based on modifiable factors have recently been developed for dementia. This study aims to estimate the cost-effectiveness of a potential preventive intervention program meant to lower the score related to increased dementia risk. Analyses were based on a Markov model adapted to Swedish circumstances. Risk score categories and risk probabilities were derived from the Cardiovascular Risk Factors, Aging and Incidence of Dementia (CAIDE) study in Finland. Figures of costs, utilities, and mortality were obtained from literature or databases. One-way sensitivity analysis and probabilistic sensitivity analysis were carried out to investigate the robustness of the model and to identify which model inputs had most impact on the results. In the base case, the usual care had a cost of 621,000 SEK and utilities of 11.8438 quality-adjusted life year (QALYs). The intervention had a cost of 599, 026 SEK and utilities of 11.8950 QALYs. The cost was 21,974 SEK lower in the intervention with 0.0511 QALYs gained over a 20 years horizon, indicating absolute dominance. The support for cost-effectiveness was insensitive to changes in the value of QALY for demented, mortality, and risk of dementia. If the intervention program was assumed to run every year, the incremental cost-effectiveness ratio did not show absolute dominance but was still under the willingness-to-pay level. The probabilistic sensitivity analysis indicated cost effectiveness in 67% of the samplings given a willingness-to-pay level of 600,000 SEK/year. This is a promising outlook for future research on preventive interventions in dementia, emphasizing the need of conducting multi-domain randomized trials.
基于可改变因素的风险评分最近已被开发用于痴呆症。本研究旨在评估一项旨在降低与痴呆风险增加相关评分的潜在预防干预计划的成本效益。分析基于适用于瑞典情况的马尔可夫模型。风险评分类别和风险概率源自芬兰心血管风险因素、衰老和痴呆症发生率(CAIDE)研究。成本、效用和死亡率数据来自文献或数据库。进行了单因素敏感性分析和概率敏感性分析,以考察模型的稳健性,并确定对结果影响最大的模型输入。在基础情况下,常规护理的成本为 621,000 瑞典克朗,效用为 11.8438 个质量调整生命年(QALY)。干预的成本为 599,026 瑞典克朗,效用为 11.8950 QALY。干预组的成本降低了 21,974 瑞典克朗,在 20 年的时间内增加了 0.0511 个 QALY,表明具有绝对优势。在考虑到痴呆患者的 QALY 值、死亡率和痴呆风险的变化时,对成本效益的支持是不敏感的。如果假设干预计划每年进行一次,增量成本效益比虽然不具有绝对优势,但仍低于支付意愿水平。概率敏感性分析表明,在支付意愿水平为 600,000 瑞典克朗/年的情况下,该方案在 67%的抽样中具有成本效益。这为未来针对痴呆症的预防干预措施的研究提供了一个有希望的前景,强调了进行多领域随机试验的必要性。